We subsequently showed that blocking HA-CD44 signaling by IGFBP-3 resulted in increased levels of acetylcholinesterase in A549 cell media but not in the media of H1299 (p53-null) lung cancer cells, effects that correlated with a greater reduction in A549 cell viability51. This evidence concerns the gene IGFBP3 and lung cancer.